Jiangsu Huajing Molecular Imaging & Drug Research Institutes Co., Ltd. （Huajing）is a leading molecular imaging contract research organization (CRO) company located in China. Huajing established a one-stop platform that provides services for new drug development using radiolabeling and molecular imaging techniques. The platform offers compound radiolabeling, radiolabeling ADME as well as PET/SPECT/CT/MRI imaging integrated services for drug screening, bio-distribution, pharmacokinetics and pharmacodynamics.
Hua Jing is AAALAC accredited and provides translational research services from nude mice, rats, non-human primates to humans.The company mainly focuses on cancer, coronary heart, neurodegenerative diseases, epilepsy, rheumatoid arthritis, diabetes, gene expression, and stem cell research etc. Huajing takes advantage of PET/SPECT/MRI molecular imaging system ( in vivo imaging, dynamic quantitative, self-control and continuous observation) to accelerate building strong pipelines for R&D.
